PubRank

Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

Clinical Trial ID NCT02493049

PubWeight™ 0.85‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02493049

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998 12.21
2 Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002 3.28
3 Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003 2.60
4 Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009 2.43
5 Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000 2.08
6 Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". Neurology 2001 1.76
7 The effect of two different domperidone doses on maternal milk production. J Hum Lact 2012 1.65
8 Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003 1.55
9 White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 2007 1.54
10 Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 2003 1.43
11 Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry 2007 1.17
12 Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic. CNS Drugs 2013 1.10
13 Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2004 1.08
14 MRI-based myelin water imaging: A technical review. Magn Reson Med 2014 1.03
15 Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 2008 0.93
16 Mechanisms of CNS remyelination--the key to therapeutic advances. J Neurol Sci 2005 0.91
17 Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis. Nat Rev Drug Discov 2016 0.85
18 Reduction of microglial activity in a model of multiple sclerosis by dipyridamole. J Neuroinflammation 2013 0.82
19 Imaging outcomes for trials of remyelination in multiple sclerosis. J Neurol Neurosurg Psychiatry 2014 0.82
20 Prolactin responses to domperidone in chronic schizophrenia. Psychiatry Res 1992 0.75
21 Humoral effects of metoclopramide and domperidone in normal subjects and in hypertensive patients. J Endocrinol Invest 1988 0.75
Next 100